Cardiovascular outcomes in patients with bullous pemphigoid on rituximab compared to those on systemic corticosteroids: A propensity - matched retrospective study using the TriNetX database

Supplemental materials as study methods and results.
Figure S1. The study flowchart
Table S1. Baseline characteristics of study subjects (before and after PSM matching)
Table S2. Risk of Cardiovascular Outcomes in Patients with Bullous Pemphigoid Treated with Rituximab vs Steroids, Stratified by Duration of Follow-Up
Table S3. Case number and Risk of Cardiovascular Outcomes in Patients With Bullous Pemphigoid Treated With Rituximab vs Steroids,(1 day to 1 year)
Table S4. Risk of outcome (1 day to 1 year) PSM with different variables
Table S5. Steroids used in this study:
Detailed study design and data source are included in the supplementary file